Skip to main content

Table 1 Clinical and laboratory data from participants included in the study

From: 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

Characteristics

Patients

1

2

3

4

5

6

7

8

9

Age

61

66

70

80

72

86

62

66

62

Sex

F

M

M

M

M

M

M

M

M

Diagnosis

AL Lambda

AL Lambda

AL Kappa

HCM

AL Lambda

HCM

AL Lambda

AL Lambda

AL Lambda

Biopsy

Abdominal Fata

Tongue

Lungs

BMb

Kidneys

Myocardial BMa

Abdominal fat

BMb

GI

BMb

Kidneys

Organs involvementa

Heart

Kidney

Larynx/GI

Heart

Kidneys

Heart

Kidneys

Heart

Troponin I (< 0.1 ng/ml)

< 0.1

< 0.1

< 0.1

< 0.1

1.986

< 0.1

< 0.01

< 0.1

0.08

NT-proBNP (< 300 mg/ml)

2.086

8.804

631

3.188

1.804

N/A

330

183

575

Creatinine (0.50–1.2 mg/dl)

0.49

1.6

1.76

1.45

1.66

1.03

0.7

1.8

2.61

Alb/creat ratio (< 30 mg/g)

2.214

1.972

54

N/A

N/A

N/A

N/A

N/A

N/A

Free Lambda light chain (0.6–2.6 mg/dl)

3.1

16.7

1

N/A

0.3

N/A

2.7

4.3

8.4

Free Kappa light chain (0.3–2.0 mg/dl)

1.5

1.5

1.7

N/A

0.1

N/A

0.4

3.5

9.2

Free K/L ratio (0.3–1.6)

0.4

0.1

1.7

N/A

0.3

N/A

0.1

0.8

1.1

  1. N/A not available
  2. aOrgans involvement was diagnosed by patient 1: myocardium (echo), kidneys (laboratory), laryngeal/GI (clinically); patient 2: myocardium (cardiac MRI), kidneys (laboratory); patient 7: myocardium (echo); and patient 8: kidneys (laboratory)
  3. bBM biopsy was performed and was positive for plasma cells, but negative for Congo-red stain